Online repository of biological information which aims to create a knowledge base for students by the provision of animations and lectures.
Pages
Lecture on HDAC Inhibitors
James Rusche, PhD, Sr. Vice President, Research and Development, Repligen Corporation, discusses the work his company has done to identify development candidate for Friedreich's Ataxia.
No comments:
Post a Comment